VanHimbergen Robert M 4

What Happened

• Robert M. VanHimbergen, EVP and Chief Financial Officer of Elanco Animal Health (ELAN), was granted 8.634 deferred stock units on April 3, 2026. The units are reported at $22.82 each for a total reported value of $197. This was an award of derivative units (transaction code A), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-04-03; Filing date: 2026-04-07 (filed within the typical two-business-day Form 4 window).
• Instrument: 8.634 deferred stock units (derivative), $22.82 per unit, total $197.
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — each deferred stock unit represents the right to receive one share or the cash equivalent; F2 — units settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.
• Transaction type: Award/Grant (routine compensation), not a buy or sale.

Context

• Deferred stock units are a form of compensation that typically convert into shares or cash at a later date (e.g., upon separation or in a set future year). Such awards are routine and do not necessarily reflect immediate insider buying or selling intent. The reported dollar amount here is small (~$197), indicating a modest award.